Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Shares Outstanding (2016 - 2025)

Vanda Pharmaceuticals (VNDA) has disclosed Shares Outstanding for 17 consecutive years, with $59.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.36% to $59.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.1 million through Dec 2025, up 1.36% year-over-year, with the annual reading at $59.1 million for FY2025, 1.36% up from the prior year.
  • Shares Outstanding hit $59.1 million in Q4 2025 for Vanda Pharmaceuticals, roughly flat from $59.1 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $59.1 million in Q4 2025 to a low of $55.6 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $57.4 million across 5 years, with a median of $57.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding: grew 2.64% in 2021 and later rose 1.27% in 2025.
  • Year by year, Shares Outstanding stood at $55.9 million in 2021, then increased by 1.58% to $56.8 million in 2022, then grew by 1.32% to $57.5 million in 2023, then increased by 1.35% to $58.3 million in 2024, then increased by 1.36% to $59.1 million in 2025.
  • Business Quant data shows Shares Outstanding for VNDA at $59.1 million in Q4 2025, $59.1 million in Q3 2025, and $59.1 million in Q2 2025.